308 results on '"Fischer, Anne-marie"'
Search Results
2. Examens complémentaires pour l’exploration d’une consommation de facteurs de la coagulation
3. Cytogénétique hématologique
4. Cytologie
5. Groupes sanguins érythrocytaires
6. Examens complémentaires pour l’exploration d’un syndrome hémorragique
7. Exploration des proliférations myéloïdes
8. Exploration des pathologies érythrocytaires
9. Autres contextes clinico-biologiques
10. Anticorps anti-érythrocytaires
11. Exploration des anomalies de l’hémoglobine
12. Exploration des anomalies du métabolisme du fer et hémolyse
13. Autres techniques moléculaires
14. Maladie résiduelle moléculaire
15. Exploration des facteurs de risque biologiques de maladie thromboembolique
16. Suivi biologique des traitements antithrombotiques
17. Cytométrie en flux
18. Tests globaux et facteurs de coagulation
19. Exploration des proliférations lymphoïdes
20. Annexes
21. Diagnostic d’exclusion de maladie thromboembolique veineuse
22. Autres anticorps anti-éléments figurés du sang
23. Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis
24. A motif within the N-terminal domain of TSP-1 specifically promotes the proangiogenic activity of endothelial colony-forming cells
25. Clinical, biological, and genetic features in an afibrinogenemia patient series in Algeria
26. Platelet Microparticles: A Potential Predictive Factor of Survival in Hormone-Refractory Prostate Cancer Patients Treated with Docetaxel-Based Chemotherapy
27. Characterization of a homozygous Gly11Val mutation in the Gla domain of coagulation factor X
28. Mechanistic study of the proangiogenic effect of osteoprotegerin
29. Human Follicular Fluid Heparan Sulfate Contains Abundant 3-O-Sulfated Chains with Anticoagulant Activity
30. Effect of oversulfated dermatan sulfate derivatives on platelet aggregation
31. Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy
32. Endothelial colony-forming cells from patients with paroxysmal nocturnal haemoglobinuria are not PIGA mutated
33. Tie2-dependent knockout of α6 integrin subunit in mice reduces post-ischaemic angiogenesis
34. Antiphospholipid antibodies in patients with paroxysmal nocturnal haemoglobinuria receiving eculizumab
35. Absence of mutation in the RAB27B gene in patients with platelet delta-storage pool deficiency
36. Endothelial dysfunction in systemic lupus patients with low disease activity: evaluation by quantification and characterization of circulating endothelial microparticles, role of anti-endothelial cell antibodies
37. Inherited factor VII deficiency: identification of two novel mutations (A191V and T239P) in the catalytic domain
38. Low-molecular-weight fucoidan enhances the proangiogenic phenotype of endothelial progenitor cells
39. Effect of an oversulfated exopolysaccharide on angiogenesis induced by fibroblast growth factor-2 or vascular endothelial growth factor in vitro
40. Effect of Low Molecular Weight Fucoidan and Low Molecular Weight Heparin in a Rabbit Model of Arterial Thrombosis
41. Recurrence of a Phe31Ser mutation in the Gla domain of blood coagulation factor X, in unrelated Algerian families: a founder effect?
42. Quinidine-Induced Lupus Anticoagulant, Hypoprothrombinemia, and Antiprothrombin Antibodies
43. Characterization of two novel splice site mutations in human factor VII gene causing severe plasma factor VII deficiency and bleeding diathesis
44. Factors V Leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis
45. Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation
46. Effect of fucoidan on fibroblast growth factor-2-induced angiogenesis in vitro
47. Prevalence of the FVQ506 (Factor V Leiden) Mutation in the Normal and Thrombophilic Algerian Population
48. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia
49. Characterization, chemical modifications and in vitro anticoagulant properties of an exopolysaccharide produced by Alteromonas infernus
50. Inactivation of Thrombin by a Fucosylated Chondroitin Sulfate from Echinoderm
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.